Cancer drugs cause large cells that resist treatment; scientist aims to stop it

May 28, 2020

A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy itself, these rogue cells are becoming very large with twice or quadruple the […]

Lymphoma



Cancer researchers locate drivers of tumor resistance

May 18, 2020

Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. By studying tumors in cell lines, mice and human samples, the team documented genetic signals that promote the conversion of cancer cells from one stage […]

Erase Cancer


AAMDS webinar for patients: Understanding the overlap between MDS and MPNs

May 15, 2020

Ruben Mesa, M.D., FACP, was the featured speaker during a webinar for patients sponsored by the Aplastic Anemia & MDS International Foundation. Dr. Mesa discusses the overlap between MDS (myelodysplastic sydromes) and MPNs (myeloproliferative neoplasms), including diagnosis and treatment options and the latest in clinical trials. He also provides an update on the impact of […]